Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors  Sean M. Parker, BS, R. Alfredo Siochi,

Published byThomasine Booth Modified over 5 years ago

Similar presentations

Presentation on theme: "Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors  Sean M. Parker, BS, R. Alfredo Siochi,"— Presentation transcript:

1 Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors  Sean M. Parker, BS, R. Alfredo Siochi, PhD, Sijin Wen, PhD, Malcolm D. Mattes, MD  Practical Radiation Oncology  Volume 9, Issue 1, Pages e90-e97 (January 2019) DOI: /j.prro Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

2 Figure 1 Kaplan-Meier plots showing (A) overall survival for primary (solid) and metastatic (dashed) tumors, (B) local control for both primary and metastatic tumors, (C) PFS for patients with metastatic tumors, and (D) DFS for primary tumors. Abbreviations: PFS = progression-free survival; DFS = disease-free survival. Practical Radiation Oncology 2019 9, e90-e97DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

3 Figure 2 Kaplan-Meier plots showing local control between small (<5 cm; solid) and large (≥5 cm; dashed) tumors. Practical Radiation Oncology 2019 9, e90-e97DOI: ( /j.prro ) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

Download ppt "Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors  Sean M. Parker, BS, R. Alfredo Siochi,"

Similar presentations

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.
Su K. Metcalfe, MD, MPH, Michael T

Su K. Metcalfe, MD, MPH, Michael T
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,

The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S
Brenda G. Clark, PhD, Robert J

Brenda G. Clark, PhD, Robert J
The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis  Annemarie T. Fernandes, BA, Eric.

The Role of Radiation Therapy in Malignant Thymoma: A Surveillance, Epidemiology, and End Results Database Analysis  Annemarie T. Fernandes, BA, Eric.
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer 
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree  Justin M. Haseltine, BSE,

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree  Justin M. Haseltine, BSE,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base  Amy C. Moreno,

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base  Amy C. Moreno,
Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR  Shang-Gin Wu, MD, Yao-Wen Kuo, MD, Yih-Leong Chang,

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR  Shang-Gin Wu, MD, Yao-Wen Kuo, MD, Yih-Leong Chang,

Similar presentations

Ads by Google